The relevance of alternative RNA splicing to pharmacogenomics.
about
Resveratrol, by modulating RNA processing factor levels, can influence the alternative splicing of pre-mRNAsIdentification and analysis of ancestral hominoid transcriptome inferred from cross-species transcript and processed pseudogene comparisonsThe (in)dependence of alternative splicing and gene duplicationProteomic characterization of novel alternative splice variant proteins in human epidermal growth factor receptor 2/neu-induced breast cancersLibraries enriched for alternatively spliced exons reveal splicing patterns in melanocytes and melanomas.An annotation infrastructure for the analysis and interpretation of Affymetrix exon array data.A procedure for identifying homologous alternative splicing events.Different alternative splicing patterns are subject to opposite selection pressure for protein reading frame preservation.Identification of alternatively spliced transcripts using a proteomic informatics approachCharacterization of alternative spliceoforms and the RNA splicing machinery in pancreatic cancer.Analysis of genetic interaction networks shows that alternatively spliced genes are highly versatile.Distinct expression profiles for PTEN transcript and its splice variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome.ASEtrap: a biological method for speeding up the exploration of spliceomes.Identification and characterization of alternative splicing in parasitic nematode transcriptomes.NF1 gene loss of heterozygosity and expression analysis in sporadic colon cancerPersonalised medicine for cancer: from drug development into clinical practice.Alternative splicing: functional diversity among voltage-gated calcium channels and behavioral consequences.Steroid hormone receptor gene polymorphisms and osteoporosis: a pharmacogenomic review.Alternative splicing of 3-hydroxy-3-methylglutaryl coenzyme A reductase is associated with plasma low-density lipoprotein cholesterol response to simvastatinUpdate on the pharmacogenetics of the vitamin D receptor and osteoporosis.Integrative transcriptome sequencing identifies trans-splicing events with important roles in human embryonic stem cell pluripotency.Identification and functional analyses of 11,769 full-length human cDNAs focused on alternative splicing.Splicing variants impact in thyroid normal physiology and pathological conditions.PolyMAPr: programs for polymorphism database mining, annotation, and functional analysis.Abnormalities in Alternative Splicing of Apoptotic Genes and Cardiovascular Diseases.Differentially expressed three non-coding alternate exons at 5' UTR of regulatory type I beta subunit gene of mouse.Targeting Splicing in Prostate Cancer.
P2860
Q21134933-D7896236-C512-4E19-9EE7-C553B08A9720Q28757526-50D6130B-2664-4F6A-9849-302C0511E93EQ30360130-797A999A-FAB7-4FB9-955E-D3D0BC5A5A02Q30388028-F69C39FB-8489-4D51-82E4-8E8FC59FA775Q30780305-F48D0D6E-E1BD-4BB9-9C51-DA560EA44E91Q31112416-982F2F43-0DFF-4A20-AF1D-084743D57FDBQ33291273-9551CE61-6AAF-44D9-9079-EA0169AF2336Q33300610-6F47135B-A816-405E-9C71-178A009348FBQ34010836-F9C53181-C264-49C8-945C-2000A4F1FF55Q34570685-522B4EA3-0DE0-4D86-A728-5EBEB053A73DQ34586190-1A145540-C36F-40BE-9A3F-9E30C7702356Q34658356-9AA0A805-F4EF-4D23-A93F-4D020E19966AQ34684404-F9BBDAD6-E9B3-4BF3-8A86-39EB0522261FQ35136984-01BFFD70-0D2B-49AB-BF08-AE9ADE394F3FQ35598163-17F25FE6-6427-4DC9-BD2E-BA96F7996AA7Q36221957-511A1743-F673-461E-A5E2-91230601B399Q36763193-9197C02E-382B-4D05-9EF1-62B15158DC05Q36765764-AF8ACD40-B5C1-474E-BD3E-1AEE1F44061AQ37287003-2A39DD64-E458-464E-A150-9481CCA24682Q37416122-728CC284-451C-4150-8D20-84428BFD2958Q37420342-864CEDFD-4369-4599-B2DA-9D8651BF5E2CQ37429412-7B4E9A18-ACE4-4B6B-9934-CAAC67B2CB10Q37628520-3118D536-FD2E-487D-873F-1A604EBBF1B2Q38332193-278414A7-87D9-4A67-BD59-F5717361AC7FQ38637311-8972EEE1-8A68-4D44-89A3-FA6653B9EAB0Q44239602-9FF13139-0072-40F7-9EF6-D61BBD37F1FAQ55128284-3CFD41DC-0499-48FD-BB49-F851ABB50CE8
P2860
The relevance of alternative RNA splicing to pharmacogenomics.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The relevance of alternative RNA splicing to pharmacogenomics.
@ast
The relevance of alternative RNA splicing to pharmacogenomics.
@en
type
label
The relevance of alternative RNA splicing to pharmacogenomics.
@ast
The relevance of alternative RNA splicing to pharmacogenomics.
@en
prefLabel
The relevance of alternative RNA splicing to pharmacogenomics.
@ast
The relevance of alternative RNA splicing to pharmacogenomics.
@en
P1476
The relevance of alternative RNA splicing to pharmacogenomics.
@en
P2093
Jonathan Kearsey
Laurent Bracco
P304
P356
10.1016/S0167-7799(03)00146-X
P577
2003-08-01T00:00:00Z